HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nicolas Chapuis Selected Research

Nicolas Chapuis Research Topics

Disease

17Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 08/2007
12Neoplasms (Cancer)
01/2022 - 08/2009
5COVID-19
06/2022 - 01/2020
4Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2022 - 03/2016
2Leukemia
01/2020 - 06/2013
2Anemia
01/2019 - 03/2016
1Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
01/2022
1Oncogene Addiction
01/2022
1Hematologic Neoplasms (Hematological Malignancy)
01/2022
1Critical Illness (Critically Ill)
01/2022
1Acute Promyelocytic Leukemia
01/2022
1Philadelphia Chromosome
12/2021
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2021
1Pathologic Neovascularization
11/2021
1Multiple Myeloma
08/2021
1Overweight
07/2021
1Inflammation (Inflammations)
07/2021
1Pneumonia (Pneumonitis)
01/2021
1Lymphoma (Lymphomas)
01/2021
1Melanoma (Melanoma, Malignant)
11/2016
1Nerve Sheath Neoplasms (Nerve Sheath Neoplasm)
06/2016
1Plexiform Neurofibroma
06/2016
1Neurofibrosarcoma (MPNST)
06/2016
1Carcinoma (Carcinomatosis)
11/2015
1Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
06/2013
1Leukopenia
08/2012
1Ascites
08/2012
1Pleural Effusion (Pleural Effusions)
08/2012
1Edema (Dropsy)
08/2012
1Thrombocytopenia (Thrombopenia)
08/2012
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2012
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2012

Drug/Important Bio-Agent (IBA)

7Mechanistic Target of Rapamycin Complex 1IBA
06/2016 - 01/2008
6TOR Serine-Threonine KinasesIBA
11/2013 - 01/2008
5Proteins (Proteins, Gene)FDA Link
01/2022 - 08/2009
3Leukocyte L1 Antigen Complex (Calgranulin)IBA
06/2022 - 01/2020
3Pharmaceutical PreparationsIBA
01/2021 - 07/2011
3Sirolimus (Rapamycin)FDA Link
06/2016 - 08/2009
3Phosphatidylinositols (Phosphatidylinositol)IBA
04/2012 - 08/2007
3MTOR InhibitorsIBA
04/2012 - 12/2009
2Biomarkers (Surrogate Marker)IBA
06/2022 - 07/2021
2Monoclonal AntibodiesIBA
08/2021 - 01/2021
2HematinicsIBA
01/2019 - 03/2016
2Glutamine (L-Glutamine)FDA Link
09/2015 - 11/2013
2Metformin (Glucophage)FDA LinkGeneric
07/2011 - 11/2010
2Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2008 - 08/2007
1AlarminsIBA
06/2022
1trametinibIBA
01/2022
1eprenetapoptIBA
01/2022
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2022
1Biological ProductsIBA
01/2022
1Etoposide (VP 16)FDA LinkGeneric
01/2022
1ponatinibIBA
12/2021
1asciminibIBA
12/2021
1Fibrin Fibrinogen Degradation ProductsIBA
11/2021
1CytokinesIBA
11/2021
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
11/2021
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2021
1Interleukin-1 (Interleukin 1)IBA
11/2021
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2021
1Interleukin-6 (Interleukin 6)IBA
07/2021
1ischemia-modified albuminIBA
07/2021
1Sulfhydryl Compounds (Thiols)IBA
07/2021
1Advanced Oxidation Protein Products (AOPP)IBA
07/2021
1Brentuximab VedotinIBA
01/2021
1Interferon-gamma (Interferon, gamma)IBA
01/2021
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
01/2021
11- ((2- ((2- chloropyridin- 4yl)amino)- 4'- (cyclopropylmethyl)- (4,5'- bipyrimidin)- 2'- yl)amino)- 2- methylpropan- 2- olIBA
10/2020
1IronIBA
01/2020
1RNA (Ribonucleic Acid)IBA
01/2020
1HLA Antigens (Human Leukocyte Antigens)IBA
01/2020
1Ferritins (Ferritin)IBA
01/2019
1HepcidinsIBA
01/2019
1ErythropoietinFDA Link
01/2019
1Hemoglobins (Hemoglobin)IBA
01/2019
1guanosine 5'-monophosphorothioateIBA
01/2017
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
11/2016
1VemurafenibIBA
11/2016
1Proliferating Cell Nuclear Antigen (PCNA)IBA
10/2016
1Adenosine Triphosphate (ATP)IBA
06/2016
1Mechanistic Target of Rapamycin Complex 2IBA
06/2016
1(5- (2,4- bis((3S)- 3- methylmorpholin- 4- yl)pyrido(2,3- d)pyrimidin- 7- yl)- 2- methoxyphenyl)methanolIBA
06/2016
1Immunoglobulin G (IgG)IBA
03/2016
1APG101IBA
03/2016
11-dodecylpyridoxal (PLD)IBA
11/2015
1liposomal doxorubicin (Doxil)FDA Link
11/2015
1Sorafenib (BAY 43-9006)FDA Link
06/2013
1Dasatinib (BMS 354825)FDA Link
08/2012
1Cytostatic AgentsIBA
04/2012
1romiplostimFDA Link
01/2012
1Thrombopoietin ReceptorsIBA
01/2012
1AICA ribonucleotide (ZMP)IBA
07/2011
1BiguanidesIBA
11/2010
1Transcription Factors (Transcription Factor)IBA
11/2010
1Phosphotransferases (Kinase)IBA
11/2010

Therapy/Procedure

11Therapeutics
01/2022 - 10/2008
2Drug Therapy (Chemotherapy)
12/2020 - 12/2011
1Mechanical Ventilators (Ventilator)
01/2021
1Heterologous Transplantation (Xenotransplantation)
11/2013
1Salvage Therapy
01/2012